141 related articles for article (PubMed ID: 8423715)
1. Ni-DTPA doped agarose gel--a phantom material for Gd-DTPA enhancement measurements.
Tofts PS; Shuter B; Pope JM
Magn Reson Imaging; 1993; 11(1):125-33. PubMed ID: 8423715
[TBL] [Abstract][Full Text] [Related]
2. The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat.
Shuter B; Tofts PS; Wang SC; Pope JM
Magn Reson Imaging; 1996; 14(3):243-53. PubMed ID: 8725190
[TBL] [Abstract][Full Text] [Related]
3. T1 relaxivities of gadolinium-based magnetic resonance contrast agents in human whole blood at 1.5, 3, and 7 T.
Shen Y; Goerner FL; Snyder C; Morelli JN; Hao D; Hu D; Li X; Runge VM
Invest Radiol; 2015 May; 50(5):330-8. PubMed ID: 25658049
[TBL] [Abstract][Full Text] [Related]
4. 1H T1 and T2 measurements of the MR imaging contrast agents Gd-DTPA and Gd-DTPA BMA at 1.5T.
Reichenbach JR; Hackländer T; Harth T; Hofer M; Rassek M; Mödder U
Eur Radiol; 1997; 7(2):264-74. PubMed ID: 9038129
[TBL] [Abstract][Full Text] [Related]
5. High resolution NMR imaging: Gd-DTPA labeled enzyme as a probe for permeability studies in polyacrylamide gels.
Spanoghe M; Lanens D; Gorrebeeck C; Dommisse R; Lemière G; Van der Linden A; Van de Vyver F
Magn Reson Imaging; 1991; 9(4):583-7. PubMed ID: 1779730
[TBL] [Abstract][Full Text] [Related]
6. Pseudolayering of Gd-DTPA in the urinary bladder.
Elster AD; Sobol WT; Hinson WH
Radiology; 1990 Feb; 174(2):379-81. PubMed ID: 2296649
[TBL] [Abstract][Full Text] [Related]
7. NMRD assessment of Gd-DTPA-bis(methoxyethylamide), (Gd-DTPA-BMEA), a nonionic MRI agent.
Adzamli K; Periasamy MP; Spiller M; Koenig SH
Invest Radiol; 1999 Jun; 34(6):410-4. PubMed ID: 10353033
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium-containing copolymeric chelates--a new potential MR contrast agent.
Unger EC; Shen D; Wu G; Stewart L; Matsunaga TO; Trouard TP
MAGMA; 1999 Aug; 8(3):154-62. PubMed ID: 10504042
[TBL] [Abstract][Full Text] [Related]
9. Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla.
Pintaske J; Martirosian P; Graf H; Erb G; Lodemann KP; Claussen CD; Schick F
Invest Radiol; 2006 Mar; 41(3):213-21. PubMed ID: 16481903
[TBL] [Abstract][Full Text] [Related]
10. Studies of Gd-DTPA relaxivity and proton exchange rates in tissue.
Donahue KM; Burstein D; Manning WJ; Gray ML
Magn Reson Med; 1994 Jul; 32(1):66-76. PubMed ID: 8084239
[TBL] [Abstract][Full Text] [Related]
11. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates?
Gibby W; Parish W; Merrill RM; Fernandez D; Anderson CR; Merchel E; Parr R
Magn Reson Imaging; 2019 May; 58():76-81. PubMed ID: 30639754
[TBL] [Abstract][Full Text] [Related]
12. Gd-DTPA: an alternative contrast medium for CT.
Quinn AD; O'Hare NJ; Wallis FJ; Wilson GF
J Comput Assist Tomogr; 1994; 18(4):634-6. PubMed ID: 8040451
[TBL] [Abstract][Full Text] [Related]
13. Formulation of radiographically detectable gastrointestinal contrast agents for magnetic resonance imaging: effects of a barium sulfate additive on MR contrast agent effectiveness.
Rubin DL; Muller HH; Young SW
Magn Reson Med; 1992 Jan; 23(1):154-65. PubMed ID: 1734177
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of DTPA analogues derived from piperidine and azepane: potential contrast enhancement agents for magnetic resonance imaging.
Chong HS; Garmestani K; Bryant LH; Brechbiel MW
J Org Chem; 2001 Nov; 66(23):7745-50. PubMed ID: 11701031
[TBL] [Abstract][Full Text] [Related]
15. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization.
Ogan MD; Schmiedl U; Moseley ME; Grodd W; Paajanen H; Brasch RC
Invest Radiol; 1987 Aug; 22(8):665-71. PubMed ID: 3667174
[TBL] [Abstract][Full Text] [Related]
16. Biodistribution of GdCl3 and Gd-DTPA and their influence on proton magnetic relaxation in rat tissues.
Barnhart JL; Kuhnert N; Bakan DA; Berk RN
Magn Reson Imaging; 1987; 5(3):221-31. PubMed ID: 3626790
[TBL] [Abstract][Full Text] [Related]
17. Intraindividual comparison of T1 relaxation times after gadobutrol and Gd-DTPA administration for cardiac late enhancement imaging.
Doeblin P; Schilling R; Wagner M; Luhur R; Huppertz A; Hamm B; Taupitz M; Durmus T
Eur J Radiol; 2014 Apr; 83(4):660-4. PubMed ID: 24433640
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of relaxivity rates of Gd-DTPA complexes by intercalation into layered double hydroxide nanoparticles.
Xu ZP; Kurniawan ND; Bartlett PF; Lu GQ
Chemistry; 2007; 13(10):2824-30. PubMed ID: 17186555
[TBL] [Abstract][Full Text] [Related]
19. Tissue relaxation enhancement after intravenous administration of (ITCB-DTPA)-gadolinum conjugated albumin, an intravascular magnetic resonance imaging contrast agent.
Niemi P; Koskinen S; Reisto T
Invest Radiol; 1991 Jul; 26(7):674-80. PubMed ID: 1885276
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of two new gadolinium chelates as contrast agents for MRI.
Wiegers CB; Welch MJ; Sharp TL; Brown JJ; Perman WH; Sun Y; Motekaitis RJ; Martell AE
Magn Reson Imaging; 1992; 10(6):903-11. PubMed ID: 1461088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
